Form 4: 908 Devices CEO Kevin J. Knopp Exercises Stock Options and Reports Beneficial Ownership Changes
SEC Form 4 Filing
Kevin J. Knopp, President and CEO of 908 Devices Inc., reports exercising stock options and changes in beneficial ownership of company stock.
Summary
- On April 16, 2024, Kevin J. Knopp, the President and CEO of 908 Devices Inc., executed transactions involving the company's stock.
- Knopp exercised stock options to acquire 47,000 shares of common stock at a price of $1.75 per share.
- Following the transaction, Knopp directly owns 458,981 shares and indirectly owns 541,223 shares.
- The indirectly held shares are owned by The Kevin J. Knopp Irrevocable Trust of 2018, for which Knopp may be deemed a beneficial owner.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral. It simply reports transactions by a company insider.
Positives
- The exercise of stock options by the CEO could be interpreted as a sign of confidence in the company's future prospects.
Industry Context
This filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their transactions in the company's stock. It is common for executives to have stock options as part of their compensation packages.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding the CEO's investment in the company.
Key Dates
| Date | Description |
|---|---|
| 01/01/2027 | Expiration date of stock options |
| 04/16/2024 | Date of transaction: stock option exercise and reporting of beneficial ownership changes |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.